Technology
Health
Biotechnology

Selecta Biosciences

$2.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.18 (7.14%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell SELB and other stocks, options, ETFs, and crypto commission-free!

About

Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. it produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. The firm proprietary pipeline includes SVP-enabled enzyme, oncology and gene therapies. Read More The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian in 2007 and is headquartered in Watertown, MA.

Employees
39
Headquarters
Watertown, Massachusetts
Founded
2007
Market Cap
56.63M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
298.09K
High Today
$2.95
Low Today
$2.61
Open Price
$2.62
Volume
366.58K
52 Week High
$16.55
52 Week Low
$1.41

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Research And Development
Gene Therapies
Pharmaceutical

News

MarketBeatFeb 26

Stock Price, News, & Analysis for Selecta Biosciences

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its proprietary pipeline includes synthetic vaccine particles (SPV)-enabled enzyme, oncology, and gene therapies. The company's lead product is SEL-212 that in Phase II clinical trial to treat severe gout patients and resolve their symptoms, including flares and gouty arthritis. It is also developing SEL-403 product candidate, ...

616

Earnings

-$0.90
-$0.78
-$0.66
-$0.54
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.70 per share
Actual
-$0.65 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.